SARS CoV 2 News and Research

RSS

Factors affecting exercise during COVID-19 pandemic

Researchers identify the barriers and facilitators to PA during the COVID-19 pandemic across different demographic groups.

24 May 2022

COVID-19 vaccine effectiveness wanes more quickly in cancer patients, study finds

A study co-led by the Universities of Oxford, Birmingham and Southampton and the UK Health Security Agency (UKHSA), published in Lancet Oncology today by the UK Coronavirus Cancer Evaluation Project, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

24 May 2022

Insilico Medicine nominates novel preclinical candidate targeting 3CL protease for COVID-19 treatment

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced its nomination of a novel preclinical candidate (PCC) targeting 3C-like (3CL) protease for the treatment of COVID-19.

24 May 2022

Computational modeling fine tunes RBD-1C aptamer against SARS-CoV-2 S protein

Researchers used the SARS-CoV-2 sequence against aptamers to perform the in silico selection of an aptamer against the SARS-CoV-2 S protein.

24 May 2022

Common air pollutants linked to more severe outcomes after SARS-CoV-2 infection

Some common air pollutants, such as ground-level ozone, are associated with more severe outcomes after SARS-CoV-2 infection, including admission to the intensive care unit (ICU), according to new research in CMAJ.

24 May 2022

Study explores the substrate selectivity of the SARS-CoV-2 replicase

Researchers explored factors affecting substrate selection by the SARS-CoV-2 replicase.

24 May 2022

The impact of various masking practices on secondary SARS-CoV-2 transmission in a cohort of K–12 schools

Researchers evaluated the impact of masking policies in schools on the secondary transmission of COVID-19.

24 May 2022

Study compares excess mortality in Massachusetts during the Delta and initial Omicron periods

Researchers estimated excess mortality in Massachusetts during the COVID-19 Delta and early Omicron waves.

24 May 2022

The impact of SARS-CoV-2 nucleocapsid protein mutations on the performance of rapid antigen tests

The study findings showed that the rapid antigen tests with the DMS approach could accurately identify antibody escape mutations in the SARS-CoV-2 N protein.

24 May 2022

Hamster contact exposure challenge model assesses protection conferred by SARS-CoV-2 vaccination or prior infection against reinfection

Researchers assessed the neutralization efficacy of a saRNA vaccine targeting SARS-CoV-2 S protein against reinfection among hamsters with prior vaccination or infection.

24 May 2022

The effects of maternal SARS-CoV-2 infection on the newborn child

Even as the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide, interest in understanding the sequelae of the disease is growing. A new preprint research paper examines the outcomes of babies born to mothers infected with the virus during pregnancy.

24 May 2022

Findings from the CoVaccS study on parental intention to vaccinate children against COVID

In the current preprint posted to the medRxiv* server, the researchers looked at UK parental intention to vaccinate their children during a time of selective pediatric vaccination.

24 May 2022

Vaccinated individuals with SARS-CoV-2 infection develop virus-specific T cells inside their noses

In a recent study posted to the medRxiv* preprint server, investigators in Singapore showed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection elicited broadly specific virus-selective nasal resident CD8 and CD4 T cells.

24 May 2022

Efficacy study of Paxlovid and Molnupiravir in real-world settings shows positive results

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the effectiveness of oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals, molnupiravir (Lagevrio) or nirmatrelvir/ritonavir (Paxlovid) in a real-world setting.

24 May 2022

Omicron vaccine breakthrough infections induce potent cross-reactive antibodies

In a recent study published in the journal Cell, researchers demonstrated that antibodies generated due to breakthrough infection (BTI) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) new variant of concern (VOC) Omicron in vaccinated individuals could neutralize all VOCs.

24 May 2022

SARS CoV 2 News and Research

Factors affecting exercise during COVID-19 pandemic

COVID-19 vaccine effectiveness wanes more quickly in cancer patients, study finds

Insilico Medicine nominates novel preclinical candidate targeting 3CL protease for COVID-19 treatment

Computational modeling fine tunes RBD-1C aptamer against SARS-CoV-2 S protein

Common air pollutants linked to more severe outcomes after SARS-CoV-2 infection

Study explores the substrate selectivity of the SARS-CoV-2 replicase

The impact of various masking practices on secondary SARS-CoV-2 transmission in a cohort of K–12 schools

Study compares excess mortality in Massachusetts during the Delta and initial Omicron periods

The impact of SARS-CoV-2 nucleocapsid protein mutations on the performance of rapid antigen tests

Hamster contact exposure challenge model assesses protection conferred by SARS-CoV-2 vaccination or prior infection against reinfection

The effects of maternal SARS-CoV-2 infection on the newborn child

Findings from the CoVaccS study on parental intention to vaccinate children against COVID

Vaccinated individuals with SARS-CoV-2 infection develop virus-specific T cells inside their noses

Efficacy study of Paxlovid and Molnupiravir in real-world settings shows positive results

Omicron vaccine breakthrough infections induce potent cross-reactive antibodies

Biologic medications used by IBD patients boost COVID-19 vaccine response

BNT162b2 vaccine induces robust SARS-CoV-2 immunity in children

Study reveals the cross-protective role of Omicron infection in vaccinated individuals

Anti-SARS-CoV-2 antibodies persist in breast milk, even after gastrointestinal digestion

ATLAS assay reveals SARS-CoV-2 variant T-cell responses

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News